{"schema_version":"alpha-profile-public-v1","slug":"hugh-davis-ph-d","canonical_url":"https://registry.alpha.ac/people/hugh-davis-ph-d","as_of":"2026-09-22T08:02:32.913857+00:00","published_at":"2026-09-02T02:37:24.49857+00:00","last_reviewed_at":"2026-05-04T23:45:52.083+00:00","identity":{"display_name":"Harold S. Bernstein, M.D., Ph.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive","board"],"current_role":{"company_name":"Aclaris Therapeutics, Inc.","company_slug":"aclaris-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRS","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2024-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-24T20:00:01.377+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=hugh-davis-ph-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=hugh-davis-ph-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Bernstein has served as President, Head of Research and Development, and Chief Medical Officer since October 2022, previously holding senior roles at BioMarin Pharmaceutical, Vertex, and Merck. He holds an A.B. from Harvard College and an M.Phil., Ph.D. in Human Genetics and M.D. from the Icahn School of Medicine at Mount Sinai."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Aclaris Therapeutics, Inc.","organizationId":"aclaris-therapeutics-inc","title":"Director","period":"2024-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Aclaris Therapeutics, Inc.","company_slug":"aclaris-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRS","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2024-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-24T20:00:01.377+00:00"}}],"claims":[{"claim_type":"ai_expertise","claim_value":{"detail":"Dr. Pelish has served as Chief Scientific Officer since July 2024, having held progressively senior roles at Nuvalent since 2018 and contributing scientifically to the creation of the company. Prior to Nuvalent, he served as a Research Associate at Harvard University where he contributed to the discovery of a new mechanism for targeting acute myeloid leukemia cells.","ai_expertise":false},"claim_text":"SEC-derived executive row classified AI expertise as False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_governance_relevance","claim_value":{"reasons":[],"relevant":false},"claim_text":"AI-governance relevance classified as False from role/title and SEC-derived executive context.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Hugh Davis, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T20:00:12.530958+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T20:00:12.387493+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Harold S. Bernstein, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:45:52.373168+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MAZE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm","published_at":"2026-04-28T00:00:00+00:00","last_checked_at":"2026-05-04T23:45:52.189714+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"ACRS","role_type":"Director","organization":"Aclaris Therapeutics, Inc."},"claim_text":"Serves on the board of Aclaris Therapeutics, Inc. as Director.","claim_state":"verified","valid_from":"2024-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:40.400287+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Aclaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.446969+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Hugh Davis, Ph.D. currently serves as Director at Aclaris Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T20:00:12.485872+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T20:00:12.387493+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Hugh Davis, Ph.D. serves on no disclosed committees.","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T20:00:12.509753+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T20:00:12.387493+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Aclaris Therapeutics, Inc.","claim_text":"Hugh Davis, Ph.D. is linked to Aclaris Therapeutics, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T20:00:12.644553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T20:00:12.387493+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"President and Chief Operating Officer","claim_text":"Hugh Davis, Ph.D. is also listed as President and Chief Operating Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T20:00:12.625007+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T20:00:12.387493+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Hugh Davis, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T20:00:12.56616+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T20:00:12.387493+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Harold S. Bernstein, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:45:52.425269+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MAZE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm","published_at":"2026-04-28T00:00:00+00:00","last_checked_at":"2026-05-04T23:45:52.189714+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2024},"claim_text":"Director tenure at Aclaris Therapeutics, Inc. begins from 2024.","claim_state":"verified","valid_from":"2024-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:40.400287+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Aclaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.446969+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Maze Therapeutics, Inc.","claim_text":"Harold S. Bernstein, M.D., Ph.D. is associated with Maze Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-28","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:45:52.352284+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MAZE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm","published_at":"2026-04-28T00:00:00+00:00","last_checked_at":"2026-05-04T23:45:52.189714+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Nuvalent Inc","claim_text":"Henry E. Pelish, Ph.D. is associated with Nuvalent Inc.","claim_state":"verified","valid_from":"2026-02-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T19:40:57.29739+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526073317/nuvl-20251231.htm","published_at":"2026-02-26T00:00:00+00:00","last_checked_at":"2026-05-01T19:40:57.148271+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":{"ticker":"NUVL","company":"Nuvalent Inc"},"claim_text":"Henry E. Pelish, Ph.D. is associated with Nuvalent Inc.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_function","claim_value":{"role_family":"other_executive","role_type_normalized":"other_executive"},"claim_text":"Henry E. Pelish, Ph.D. maps to the other executive executive function.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"President, Research and Development and Chief Medical Officer","claim_text":"Harold S. Bernstein, M.D., Ph.D. is listed as President, Research and Development and Chief Medical Officer at Maze Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-28","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:45:52.326053+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MAZE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm","published_at":"2026-04-28T00:00:00+00:00","last_checked_at":"2026-05-04T23:45:52.189714+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Scientific Officer","claim_text":"Henry E. Pelish, Ph.D. is listed as Chief Scientific Officer at Nuvalent Inc.","claim_state":"verified","valid_from":"2026-02-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T19:40:57.274633+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526073317/nuvl-20251231.htm","published_at":"2026-02-26T00:00:00+00:00","last_checked_at":"2026-05-01T19:40:57.148271+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":{"title":"Chief Scientific Officer","role_type_normalized":"other_executive"},"claim_text":"Henry E. Pelish, Ph.D. is listed as Chief Scientific Officer at Nuvalent Inc.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:36.795186+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NUVL executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:46.329356+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":false},"claim_text":"Board independence status at Aclaris Therapeutics, Inc.: False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:40.400287+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Aclaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.446969+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"Adjunct Professor of Pediatrics (Cardiology)","company":"Icahn School of Medicine at Mount Sinai"},"claim_text":"Harold S. Bernstein, M.D., Ph.D. is also linked to Icahn School of Medicine at Mount Sinai as Adjunct Professor of Pediatrics (Cardiology).","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:45:52.464595+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MAZE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm","published_at":"2026-04-28T00:00:00+00:00","last_checked_at":"2026-05-04T23:45:52.189714+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Hugh Davis, Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-04-24T20:00:12.548305+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-04-24T20:00:12.387493+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Harold S. Bernstein, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-04T23:45:52.402673+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MAZE DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm","published_at":"2026-04-28T00:00:00+00:00","last_checked_at":"2026-05-04T23:45:52.189714+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:hugh-davis-ph-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2024-01-01 · current","organization":"Aclaris Therapeutics, Inc.","organization_id":"aclaris-therapeutics-inc"},"claim_text":"Director at Aclaris Therapeutics, Inc. (2024-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/hugh-davis-ph-d#profile","url":"https://registry.alpha.ac/people/hugh-davis-ph-d","dateModified":"2026-05-04T23:45:52.083+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/hugh-davis-ph-d#person","name":"Harold S. Bernstein, M.D., Ph.D.","url":"https://registry.alpha.ac/people/hugh-davis-ph-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Aclaris Therapeutics, Inc.","tickerSymbol":"NASDAQ: ACRS"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","memberOf":{"@type":"Organization","name":"Aclaris Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/aclaris-therapeutics-inc","tickerSymbol":"NASDAQ: ACRS"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm","name":"ACRS DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm","name":"MAZE DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312526073317/nuvl-20251231.htm","name":"NUVL 10-K executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/hugh-davis-ph-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":12,"corroborated":6,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":18,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":7,"distinct_source_count":4,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":12,"corroborated":6,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":18,"corroborated_claims":6,"sources":7,"distinct_sources":4,"role_claims":1,"last_reviewed_at":"2026-05-04T23:45:52.083+00:00","observed_at":"2026-09-22T08:02:32.913857+00:00","freshness_days":140}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"hugh-davis-ph-d","canonical_url":"https://registry.alpha.ac/people/hugh-davis-ph-d"},"publication":{"published_at":"2026-09-02T02:37:24.49857+00:00","last_reviewed_at":"2026-05-04T23:45:52.083+00:00","as_of":"2026-09-22T08:02:32.913857+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/hugh-davis-ph-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/hugh-davis-ph-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/hugh-davis-ph-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}